Pfizer Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 29, 2025: 11.83%

Pfizer Inc. EBT Margin is 11.83% for the Trailing 12 Months (TTM) ending March 29, 2025, a -463.79% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Pfizer Inc. EBT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -3.25%, a -109.46% change year over year.
  • Pfizer Inc. EBT Margin for the Trailing 12 Months (TTM) ending April 02, 2023 was 34.37%, a 16.45% change year over year.
  • Pfizer Inc. EBT Margin for the Trailing 12 Months (TTM) ending April 03, 2022 was 29.51%, a 23.57% change year over year.
  • Pfizer Inc. EBT Margin for the Trailing 12 Months (TTM) ending April 04, 2021 was 23.89%, a -29.83% change year over year.
Key Data
Date EBT Margin Operating Income Margin Gross Profit Margin EBIT Margin